Form 4 for BVS Bioventus Inc.
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-07 · accession 0001578563-24-000264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-07 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | +30.4K | 45.6K | +201% | $0 |
| D | 2024-06-11 | 2024-06-07 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | -30.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-07 | M | A | 30,400 | $0.00 | 45,552 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-07 | M | D | 30,400 | $0.00 | 0 | D | — · — to — | 30,400 Class A Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F4) The RSUs vested on June 7, 2024. |